MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advancing Drive Toward Potential New GBM Treatment
CNS Pharmaceuticals (NASDAQ: CNSP) recently announced rapid enrollment in its potentially pivotal study involving its flagship drug candidate, Berubicin, and is moving closer to reporting the results of its drive toward a new treatment for…
-
MissionIRNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Participating in Webinar Focused on Future Health Tech
Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, will be spotlighted in webinar taking place today. The webinar…
-
MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Announces Filing of Federal Lawsuit Against Research Firm
FingerMotion (NASDAQ: FNGR), a mobile services and data company, has filed a federal lawsuit against Capybara Research; the lawsuit alleges that Capybara maliciously published a defamatory article in a premediated attempt to move the public…
-
MissionIRNewsBreaks — Cepton Inc. (NASDAQ: CPTN) CEO Featured in Latest Proactive Segment
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is in the spotlight. Cepton cofounder and CEO Dr. Jun Pei is the featured guest on the latest release from Proactive. During the…
-
6G Satellite Connectivity Research Uses D-Wave Quantum Inc. (NYSE: QBTS) Solutions for Enhanced Network Optimization
D-Wave Quantum (NYSE: QBTS) recently announced that LG U+, under the leadership of CEO Hyeon Sik Hwang, worked with the Korea Advanced Institute of Science and Technology (“KAIST”) and Qunova Computing to advance the development of…
-
MissionIRNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Featured in Virtual Webcast at Lytham Partners Fall 2023 Investor Conference
SenesTech (NASDAQ: SNES), the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, presented virtually in a webcast presentation as part of of the Lytham Partners Fall 2023…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Announces Participation at Upcoming Virtual Investor Ask the CEO Conference
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured at this month’s Virtual Investor Ask…
-
MissionIRNewsBreaks — Cepton Inc. (NASDAQ: CPTN) Schedules Q3 Earnings Release, Conference Call Date
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is planning to release its third-quarter 2023 financial results on Nov. 9, 2023; the report will be released following market close. Cepton has…
-
MissionIRNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Spotlighted in Latest Episode of Bell2Bell Podcast
PaxMedica (NASDAQ: PXMD), a prominent clinical-stage biopharmaceutical company, was featured in the most recent release of the Bell2Bell podcast series. During the segment, PaxMedia CEO and chair Howard Weisman and PaxMedica corporate communications representative Buzz…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Filing of Preliminary Proxy Statement
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has filed a preliminary proxy statement with the Securities and Exchange Commission (the “SEC”) regarding a special stockholders’ meeting to be…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Raised $1.6 Million in Latest Investment Round; Looks to Advance DehydraTECH(TM) Research Operations
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, raised approximately $1.6 million from its latest round of investment in what will mark a significant milestone for the company. In September 2023, the…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Launches New Open-Source Demo Highlighting Quantum System’s Ability to Improve Cellphone Network Transmission
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services and the world’s first commercial supplier of quantum computers, has released a new open-source demonstration that highlights how the company’s Advantage(TM) annealing…
-
MissionIRNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Featured in Bell2Bell Podcast
PaxMedica (NASDAQ: PXMD), a prominent clinical-stage biopharmaceutical firm, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. PaxMedica’s CEO…
-
MissionIRNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Strengthen Position in Alternative Mental-Health Treatments Sector
Lucy Scientific Discovery (NASDAQ: LSDI), a pioneer in alternative mental-health treatments, is working to provide ingredients for effective mental-health treatment and therapies, including psilocybin and MDMA. According to a recent article spotlighting LSDI, the company…
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) ‘Innovates’ Investigational Drug with Patented Nanotechnology
Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, announced that it has innovated its investigational drug, CNM-Au8(R), with nanotechnology. Clene is evaluating…
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Files NI 43-101 Iska Iska Technical Report
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine-development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, has filed a National Instrument 43-101 (“NI 43-101”) Technical Report.…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) ‘Strikingly Different’ Road Tour Lands at Sonoma Motor Speedway
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is seeing a striking response to its Strikingly Different road tour, which is designed to offer potential customers and other interested individuals an opportunity to…
-
Pest Control Innovator SenesTech Inc. (NASDAQ: SNES) Offers Unique Solution to Tackle the Spread of Rats Amid Growing Health Concerns
Controlling rat populations and the diseases associated with them has been a concern for centuries, underlined in the public consciousness by historical plagues believed to be spread by rats, including the 14th century “Black Death”…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on Status of Commercial Vehicle Production
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released a commercial vehicle production update for its Class 3 EV cab chassis trucks and Class 1 EV cargo vans. According to the report,…
-
MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Announces Q2 2024 Results
FingerMotion (NASDAQ: FNGR), a mobile services and data company, today released its financial results for the second quarter of fiscal 2024 for the period ended Aug. 31, 2023. Among the highlights, the company reported quarterly…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Innovative Glioblastoma Treatment ‘Could Offer Hope’
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is spotlighted in a recent article focused on glioblastoma,…
-
MissionIRNewsBreaks – Safety Shot (NASDAQ: SHOT) Announces MMA Superstar Jorge “Gamebred” Masvidal as Brand Ambassador
Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, has sealed a deal with mixed martial arts (“MMA”) superstar Jorge Masvidal. The agreement calls for Masvidal to serve as brand ambassador for Safety Shot,…
-
PaxMedica Inc. (NASDAQ: PXMD) Announces Gold Sponsorship for The BRAIN Foundation’s Synchrony Symposia 2023
PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of Autism Spectrum Disorder (“ASD”) and other serious conditions with intractable neurologic symptoms, recently announced its…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Adds Smallest Machine Yet to Crime-Fighting Portfolio
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced that its crime-fighting tech portfolio is expanding with the addition of the K1 Hemisphere. According to…
-
MissionIRNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Closes on $4M Registered Direct Offering
Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, closed on its previously announced registered direct offering.…
-
Clene Inc. (NASDAQ: CLNN) Applies Patented Nanotechnology to Development of CNM-Au8(R), its Investigational Drug for ALS
October 2023 has turned into a month for the celebration of nanotechnology. On Wednesday, Oct. 4, 2023, three U.S.-based scientists, Moungi Bawendi, Louis Brus, and Aleksey Ekimov, were awarded the 2023 Nobel Prize in Chemistry…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Ongoing Diabetes Study Program to Examine its Patented DehydraTECH(TM) Technology with Launch of Human and Animal Studies for Oral GLP-1 Drugs
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its intention to launch new human and animal studies that will explore its patented DehydraTECH(TM) technology on glucagon-like peptide-1 (“GLP-1”) drugs for…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Inks Global Collaboration, License Agreement with SulfoSyn
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has granted a new global, exclusive license to SulfoSyn Limited; the license is for the exclusive global use of all nonpharmaceutical applications of Lexaria’s…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Adds Two K5 ASR Contracts to Growing List of Clients
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, is continuing to add to its list of valued clients. The company has secured two more contracts for…
-
MissionIRNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Featured in Latest Release from The Watchlist by The Market Herald
Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), a company that is advancing the next generation of nickel-sulphide projects, was in the spotlight during a recent interview released by The Watchlist by The Market Herald. During the…
-
SenesTech Inc. (NASDAQ: SNES) Eager to Work with Cities to Address Rat Crises Using Effective Fertility-Restricting Method
Once threatened by the sudden COVID-induced closure of businesses and restaurants, which forced rats to adapt by moving to residential areas in search of food or die – renowned rodentologist Bobby Corrigan estimates that hundreds…
-
MissionIRNewsBreaks – NextPlat Corp. (NASDAQ: NXPL) Announces Launch of OPKO Health Inc. (NASDAQ: OPK)-Branded Online Storefront
NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced that, through a new e-commerce distribution agreement, it will enable the online sales of OPKO Health Europe, a subsidiary of OPKO Health (NASDAQ: OPK) products…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 ASRs and K1B Emergency Communications Systems Deployed for New and Existing Customers
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, announced two new sales for its K5 ASRs and an expansion sale from an existing user of its…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Portfolio Expansion to 37 Granted Patents
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has been granted two new patents by the Canadian Intellectual Property Office (“CIPO”), increasing its portfolio to 37 granted…
-
MissionIRNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Enters into $4M Registered Direct Offering
Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, has entered into a definitive agreement for…
-
MissionIRNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Announces Positive BFS for Crawford Project
Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF) today released results from the bankable feasibility study (“BFS”) for its innovative and wholly owned Crawford Nickel Sulphide Project (“Crawford”). According to the announcement, the results confirm significantly improved…
-
MissionIRNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Reaches Agreement Regarding Reorganization of Three US Subsidiaries
RVL Pharmaceuticals (NASDAQ: RVLP), a specialty pharmaceutical company focused on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution) (“UPNEEQ”), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults, has announced a prepackaged…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS), Satispay Collaboration Results in Quantum-Hybrid App that Optimizes Customer Rewards Initiatives
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services and the world’s first commercial supplier of quantum computers, is working with Satispay, the leading Italian fintech unicorn revolutionizing mobile payments. The…
-
PaxMedica Inc. (NASDAQ: PXMD) CEO Presents ASD Pipeline and Corporate Presentation at H.C. Wainwright 25th Annual Global Investment Conference
Howard Weisman, CEO of PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (“APTs”) for the treatment of Autism Spectrum Disorder (“ASD”) and other serious conditions with intractable neurological symptoms,…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positioned to Power the Future of Clean Energy
- MissionIRNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) IP Momentum Continues with New Patents Advancing 3D ECG Technology
- Silvercorp Metals, Inc. (NYSE-A/TSX: SVM) Reports Solid Production and Revenue in Q1 FY2026
- Clene Inc. (NASDAQ: CLNN) Reports Q2 2025 Results as Company Prepares for NDA Submission and Extends Runway into 2026
- Massimo Group (NASDAQ: MAMO) Accelerates Golf Cart Market Reach with Vietnam Partnership